Sulla cima del Montale la primitiva chiesa di CampolungoTINCANI, A.Bollettino Storico Reggiano Reggio Emilia. 1982, Vol 14, Num 52, pp 81-89Article

ANTI-IGA ANTIBODIES IN TWO BROTHERS WITH SELECTIVE SERUM IGA DEFICIENCY = ANTICORPS ANTI IGA CHEZ DEUX FRERES PRESENTANT UN DEFICIT SERIQUE SELECTIF EN IGAINVERNIZZI F; BALESTRIERI G; CONSOGNO G et al.1975; ACTA HAEMATOL.; SUISSE; DA. 1975; VOL. 54; NO 5; PP. 312-320; BIBL. 2 P. 1/2Article

DETECTION OF CIRCULATING IMMUNE COMPLEXES IN ACUTE NON-LYMPHATIC LEUKAEMIC: IS IT RELIABLE.ROSSI G; BALESTRIERI G; TINCANI A et al.1983; ACTA HAEMATOLOGICA; ISSN 0001-5792; CHE; DA. 1983; VOL. 69; NO 6; PP. 404-408; BIBL. 2 P.Article

VALUTAZIONE DELL' ATTIVITA T-SOPPRESSORIA IN CORSO DI LUPUS ERITEMATOSOS SISTEMICO (LES)BALESTRIERI G; TINCANI A; FENINI G et al.1982; BOLLETTINO DELL'ISTITUTO SIEROTERAPICO MILANESE; ISSN 0021-2547; ITA; DA. 1982; VOL. 61; NO 4; PP. 330-335; ABS. ENG; BIBL. 19 REF.Article

CIRCULATING IMMUNE COMPLEXES IN HUMAN ACUTE LEUKAEMIABALESTRIERI G; TINCANI A; CATTANEO R et al.1981; BR. J. HAEMATOL.; ISSN 0007-1048; GBR; DA. 1981; VOL. 49; NO 2; PP. 269-274; BIBL. 22 REF.Article

CON A SUPPRESSOR CELL ASSAY: A FURTHER CHARACTERIZATIONMERONI PL; BALESTRIERI G; BARCELLINI W et al.1983; JOURNAL OF CLINICAL AND LABORATORY IMMUNOLOGY; ISSN 0141-2760; GBR; DA. 1983; VOL. 10; NO 3; PP. 159-163; BIBL. 20 REF.Article

CIRCULATING IMMUNE COMPLEXES IN PATIENTS WITH LUNG NEOPLAMSTINCANI A; BALESTRIERI G; MORASCHINI AT et al.1980; RIC. CLIN. LAB.; ITA; DA. 1980; VOL. 10; NO 2; PP. 397-403; BIBL. 29 REF.Article

β₂GP-1 cofactor and anticardiolipin antibodiesTINCANI, A; SPATOLA, L; BALESTRIERI, G et al.Israel journal of medical sciences. 1995, Vol 31, Num 1, pp 17-21, issn 0021-2180Conference Paper

Systemic lupus erythematosus in pregnancyTINCANI, A; BALESTRIERI, G; FADEN, D et al.Lancet (British edition). 1991, Vol 338, Num 8769, pp 756-757, issn 0140-6736Article

Tumores benignos das vias biliares = Tumeurs bénignes des voies biliaires = Benign tumours of the biliary ductsBRANDALISE, N. A; TINCANI, A. J; NAGASE, Y et al.Arquivos de gastroenterologia. 1984, Vol 21, Num 1, pp 23-28, issn 0004-2803Article

On the theoretical-numerical study of the HEXCALIBER mock-up thermo-mechanical behaviourDELL'ORCO, G; DI MAIO, P. A; GIAMMUSSO, R et al.Fusion engineering and design. 2010, Vol 85, Num 5, pp 694-706, issn 0920-3796, 13 p.Article

Methylenetetrahydrofolate reductase polymorphisms and methotrexate: no association with response to therapy nor with drug-related adverse events in an Italian population of rheumatic patientsTARABORELLI, M; ANDREOLI, L; ARCHETTI, S et al.Clinical and experimental rheumatology (Testo stampato). 2009, Vol 27, Num 3, pp 499-502, issn 0392-856X, 4 p.Article

The European Breeding Blanket Test Facility: An integrated device to test European helium cooled TBMs in view of ITERUTILI, M; TINCANI, A; AIELLO, A et al.Fusion engineering and design. 2009, Vol 84, Num 7-11, pp 1881-1886, issn 0920-3796, 6 p.Conference Paper

Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFα therapy (infliximab) in rheumatoid arthritis is associated with clinical improvementALESSANDRI, C; BOMBARDIERI, M; PAPA, N et al.Annals of the rheumatic diseases. 2004, Vol 63, Num 10, pp 1218-1221, issn 0003-4967, 4 p.Article

Inhibitory effect of IgM rheumatoid factor on immune complex solubilization capacity and inhibition of immune precipitationBALESTRIERI, G; TINCANI, A; MIGLIORINI, P et al.Arthritis and rheumatism. 1984, Vol 27, Num 10, pp 1130-1136, issn 0004-3591Article

Modèles animaux de syndrome antiphospholipides = Animal models of antiphospholipid syndromeTINCANI, A; SPATOLA, L; CINQUINI, M et al.Revue du rhumatisme (Ed. française). 1998, Vol 65, Num 11, pp 676-681, issn 1169-8330Conference Paper

Utilization of dilute Russell's Viper Venom Time to detect autoantibodies against β₂-Glycoprotein I which express anticoagulant activity in the presence but not in the absence of exogenous phospholipidsPENGO, V; BALESTRIERI, G; TINCANI, A et al.Thrombosis and haemostasis. 1997, Vol 77, Num 1, pp 123-126, issn 0340-6245Article

Differential effects of anti-β₂-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndromeGEORGE, J; BLANK, M; LEVY, Y et al.Circulation (New York, N.Y.). 1998, Vol 97, Num 9, pp 900-906, issn 0009-7322Article

Neuropsychiatric aid in children born to patients with rheumatic diseasesBOMBA, M; GALLI, J; NACINOVICH, R et al.Clinical and experimental rheumatology (Testo stampato). 2010, Vol 28, Num 5, pp 767-773, issn 0392-856X, 7 p.Article

Aspirin-interleukin-3 interrelationships in patients with anti-phospholipid syndromeFISHMAN, P; FALACH-VAKNIN, E; SREDNI, B et al.American journal of reproductive immunology (1989). 1996, Vol 35, Num 2, pp 80-84, issn 1046-7408Article

Relationship between anti-phospholipid and anti-endothelial cell antibodies III : β2 glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion moleculesDEL PAPA, N; GUIDALI, L; SPATOLA, L et al.Clinical and experimental rheumatology (Testo stampato). 1995, Vol 13, Num 2, pp 179-185, issn 0392-856XArticle

Autoantibodies and common idiotypes in men and women with sperm antibodiesEL-RŒIY, A; VALESINI, G; FRIBERG, J et al.American journal of obstetrics and gynecology. 1988, Vol 158, Num 3, pp 596-603, issn 0002-9378Article

Neuropsychological Development of Children Born to Patients With Antiphospholipid SyndromeNACINOVICH, R; GALLI, J; BOMBA, M et al.Arthritis care and research. 2008, Vol 59, Num 3, pp 345-351, issn 0893-7524, 7 p.Article

Apoptotic cell clearance in systemic lupus erythematosus. II. Role of β₂-Glycoprotein IMANFREDI, A. A; ROVERE, P; HELTAI, S et al.Arthritis and rheumatism. 1998, Vol 41, Num 2, pp 215-223, issn 0004-3591Article

Clinical significance of antineutrophil cytoplasmic autoantibodies with specificity for lactoferrin in renal diseasesSINICO, R. A; POZZI, C; RADICE, A et al.American journal of kidney diseases. 1993, Vol 22, Num 2, pp 253-260, issn 0272-6386Article